Studies have revealed that PBMCs from SLE patients overexpress IFN-α-inducible genes as compared with healthy individuals [7] and high serum IFN-α level is a heritable risk factor for SLE development [37]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.